Successful Treatment of Amyloid A-Type Amyloidosis Due to Behçet Disease With Tocilizumab

J Clin Rheumatol. 2019 Jun;25(4):43-45. doi: 10.1097/RHU.0000000000000724.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amyloid Neuropathies* / diagnosis
  • Amyloid Neuropathies* / physiopathology
  • Amyloidosis* / drug therapy
  • Amyloidosis* / etiology
  • Amyloidosis* / metabolism
  • Amyloidosis* / physiopathology
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Behcet Syndrome / complications*
  • Biopsy / methods
  • Diagnosis, Differential
  • Endoscopy, Gastrointestinal / methods
  • Humans
  • Hypesthesia / diagnosis
  • Hypesthesia / etiology
  • Kidney / pathology*
  • Male
  • Middle Aged
  • Proteinuria* / diagnosis
  • Proteinuria* / etiology
  • Serum Amyloid A Protein / analysis
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome
  • Weight Loss

Substances

  • Antibodies, Monoclonal, Humanized
  • Serum Amyloid A Protein
  • tocilizumab